Cronos Group (CRON) Projected to Post Quarterly Earnings on Thursday

Cronos Group (NASDAQ:CRON) is projected to post its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect Cronos Group to post earnings of $0.01 per share and revenue of $38.5060 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:30 AM ET.

Cronos Group Stock Performance

Shares of NASDAQ:CRON opened at $2.64 on Tuesday. The stock’s 50-day simple moving average is $2.67 and its two-hundred day simple moving average is $2.60. The stock has a market capitalization of $1.00 billion, a price-to-earnings ratio of 26.40 and a beta of 0.80. Cronos Group has a 52-week low of $1.60 and a 52-week high of $3.43.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CRON shares. Canaccord Genuity Group initiated coverage on shares of Cronos Group in a report on Tuesday, January 27th. They issued a “buy” rating on the stock. Wall Street Zen upgraded shares of Cronos Group from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Zacks Research lowered Cronos Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $2.30 target price on shares of Cronos Group in a report on Wednesday, January 14th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cronos Group in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cronos Group has an average rating of “Hold” and an average target price of $2.30.

Hedge Funds Weigh In On Cronos Group

A number of hedge funds have recently made changes to their positions in CRON. Virtu Financial LLC raised its stake in Cronos Group by 10.4% during the 4th quarter. Virtu Financial LLC now owns 52,852 shares of the company’s stock valued at $139,000 after purchasing an additional 4,990 shares during the period. Pillsbury Lake Capital LLC purchased a new stake in Cronos Group during the 4th quarter valued at approximately $4,837,000. Jump Financial LLC bought a new stake in shares of Cronos Group during the fourth quarter valued at approximately $42,000. Headlands Technologies LLC raised its position in shares of Cronos Group by 12.5% during the fourth quarter. Headlands Technologies LLC now owns 63,097 shares of the company’s stock valued at $166,000 after buying an additional 6,998 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Cronos Group in the fourth quarter worth $196,000. Institutional investors own 8.71% of the company’s stock.

Cronos Group Company Profile

Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. Headquartered in Toronto, Ontario, the company manages operations that span the full cannabis value chain, including breeding, greenhouse cultivation, extraction, product formulation and packaging. Cronos Group’s business model emphasizes innovation in product development and scalability in manufacturing to meet evolving regulatory and consumer demands.

The company’s branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.